Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Protein engineering for therapeutics, part B. Preface.

Wittrup KD, Verdine GL.

Methods Enzymol. 2012;503:xiii-xiv. doi: 10.1016/B978-0-12-396962-0.00013-6. No abstract available.

PMID:
22230575
2.
3.

Recombinant therapeutic proteins: production platforms and challenges.

Dingermann T.

Biotechnol J. 2008 Jan;3(1):90-7. Review.

PMID:
18041103
4.

Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier.

Pardridge WM, Boado RJ.

Methods Enzymol. 2012;503:269-92. doi: 10.1016/B978-0-12-396962-0.00011-2. Review.

PMID:
22230573
5.

Antibody engineering for targeted therapy of cancer: recombinant Fv-immunotoxins.

Niv R, Cohen CJ, Denkberg G, Segal D, Reiter Y.

Curr Pharm Biotechnol. 2001 Mar;2(1):19-46. Review.

PMID:
11482347
6.

Advances in radioimmunotherapy in the age of molecular engineering and pretargeting.

Sharkey RM, Goldenberg DM.

Cancer Invest. 2006 Feb;24(1):82-97. Review.

PMID:
16466997
7.

Enhancement of therapeutic protein in vivo activities through glycoengineering.

Elliott S, Lorenzini T, Asher S, Aoki K, Brankow D, Buck L, Busse L, Chang D, Fuller J, Grant J, Hernday N, Hokum M, Hu S, Knudten A, Levin N, Komorowski R, Martin F, Navarro R, Osslund T, Rogers G, Rogers N, Trail G, Egrie J.

Nat Biotechnol. 2003 Apr;21(4):414-21. Epub 2003 Mar 3.

PMID:
12612588
8.

Peptide revolution: genomics, proteomics and therapeutics.

Sawyer TK, Chorev M.

Biotechniques. 2003 Mar;34(3):594-6, 598-9. No abstract available.

PMID:
12661163
9.

Immunogenicity of protein therapeutics.

De Groot AS, Scott DW.

Trends Immunol. 2007 Nov;28(11):482-90. Epub 2007 Oct 25. Review.

PMID:
17964218
10.

Integrating cell-level kinetic modeling into the design of engineered protein therapeutics.

Rao BM, Lauffenburger DA, Wittrup KD.

Nat Biotechnol. 2005 Feb;23(2):191-4.

PMID:
15696150
11.

Protein engineering and design for drug delivery.

Murphy JR.

Curr Opin Struct Biol. 1996 Aug;6(4):541-5. Review.

PMID:
8794167
12.

Protein engineering for therapeutics, Part A. Preface.

Wittrup KD, Verdine GL.

Methods Enzymol. 2012;502:xiii-xiv. doi: 10.1016/B978-0-12-416039-2.00031-8. No abstract available.

PMID:
22208991
13.

Engineering better cytokines.

Steinman L.

Nat Biotechnol. 2003 Nov;21(11):1293-4. No abstract available.

PMID:
14595357
14.

Production of recombinant protein therapeutics in cultivated mammalian cells.

Wurm FM.

Nat Biotechnol. 2004 Nov;22(11):1393-8. Review.

PMID:
15529164
15.
16.

Manufacturing of recombinant therapeutic proteins in microbial systems.

Graumann K, Premstaller A.

Biotechnol J. 2006 Feb;1(2):164-86. Review.

PMID:
16892246
17.

Keeping dry and crossing membranes.

Fernández A.

Nat Biotechnol. 2004 Sep;22(9):1081-4. Review. No abstract available.

PMID:
15340471
18.

Engineering S-protein fragments of bovine ribonuclease A for targeted drug delivery.

Backer MV, Gaynutdinov TI, Aloise R, Przekop K, Backer JM.

Protein Expr Purif. 2002 Dec;26(3):455-61.

PMID:
12460770
20.

Antibody engineering and modification technologies.

Filpula D.

Biomol Eng. 2007 Jun;24(2):201-15. Epub 2007 Mar 31. Review.

PMID:
17466589

Supplemental Content

Support Center